Literature DB >> 10208486

Monocyte chemotactic protein-1 gene and protein expression in atherogenesis of hypercholesterolemic rabbits.

Y L Chen1, Y J Chang, M J Jiang.   

Abstract

Monocyte adherence to the endothelium and subsequent migration into the subendothelial space are important early events in atherogenesis. Monocyte chemotactic protein-1 (MCP-1) has been shown to be highly expressed in both human atheroma and advanced atherosclerotic lesions of experimental animals. To establish the temporal correlation between MCP-1 expression and plaque development, we examined the expression of MCP-1 during atherogenesis of hypercholesterolemic rabbits using Northern blot analysis, in situ hybridization, and immunohistochemistry. New Zealand White rabbits were fed with 2% cholesterol-containing diet for 1 day, 3 days, 1 week, 3 weeks or 6 weeks. The plasma levels of total cholesterol were significantly increased 3 days after cholesterol feeding and continued to increase during the entire cholesterol-feeding period. Northern blot analysis showed that MCP-1 mRNA levels remained unchanged following cholesterol feeding for up to 1 week, were higher than control levels at 3-week and increased even higher at 6-week. In situ hybridization showed that after 3 weeks of cholesterol feeding, MCP-1 mRNA expression was up-regulated in newly-formed fatty streaks and parts of tunica media in the presence or absence of fatty streaks. At 6-week, pronounced MCP-1 mRNA expression was detected with similar distribution. In contrast, MCP-1 mRNA was detected only in a few endothelial cells and adventitia in control and experimental groups feeding cholesterol up to 1-week. Immunostaining of serial sections indicated that MCP-1 was expressed by macrophages and smooth muscle cells in rabbits fed with cholesterol for 3 or 6 weeks. No MCP-1 was detected in intima or media in all other groups. These results show that a lag period exists between serum cholesterol increase and upregulation of MCP-1 expression, suggesting that cholesterol modifications (e.g. oxidation) are required to stimulate MCP-1 expression. In addition, MCP-1 expressed by both macrophages and smooth muscle cells during the initial stages of atherosclerosis is likely to contribute to the development of fatty streaks in hypercholesterolemic rabbits.

Entities:  

Mesh:

Substances:

Year:  1999        PMID: 10208486     DOI: 10.1016/s0021-9150(98)00285-8

Source DB:  PubMed          Journal:  Atherosclerosis        ISSN: 0021-9150            Impact factor:   5.162


  13 in total

1.  Leucocyte chemotaxis: Examination of mitogen-activated protein kinase and phosphoinositide 3-kinase activation by Monocyte Chemoattractant Proteins-1, -2, -3 and -4.

Authors:  J H Wain; J A Kirby; S Ali
Journal:  Clin Exp Immunol       Date:  2002-03       Impact factor: 4.330

2.  The C terminus of mouse monocyte chemoattractant protein 1 (MCP1) mediates MCP1 dimerization while blocking its chemotactic potency.

Authors:  Yao Yao; Stella E Tsirka
Journal:  J Biol Chem       Date:  2010-08-03       Impact factor: 5.157

3.  Mouse monocyte chemoattractant protein 1 (MCP1) functions as a monomer.

Authors:  Yao Yao; Stella E Tsirka
Journal:  Int J Biochem Cell Biol       Date:  2014-08-12       Impact factor: 5.085

Review 4.  Inflammatory mediators in diabetic retinopathy: Deriving clinicopathological correlations for potential targeted therapy.

Authors:  Abhishek Sheemar; Deepak Soni; Brijesh Takkar; Soumyava Basu; Pradeep Venkatesh
Journal:  Indian J Ophthalmol       Date:  2021-11       Impact factor: 1.848

5.  Expanded network of inflammatory markers of atherogenesis: where are we now?

Authors:  Seyed Hesameddin Abbasi; Mohammad Ali Boroumand
Journal:  Open Cardiovasc Med J       Date:  2010-02-23

6.  Single nucleotide polymorphisms in monocyte chemoattractant protein-1 and its receptor act synergistically to increase the risk of carotid atherosclerosis.

Authors:  Paul A Nyquist; Cherie A Winkler; Louise M McKenzie; Lisa R Yanek; Lewis C Becker; Diane M Becker
Journal:  Cerebrovasc Dis       Date:  2009-06-05       Impact factor: 2.762

Review 7.  Updates on cardiovascular comorbidities associated with psoriatic diseases: epidemiology and mechanisms.

Authors:  Kaitlyn M Yim; April W Armstrong
Journal:  Rheumatol Int       Date:  2016-05-24       Impact factor: 2.631

8.  Hypochlorite-modified albumin colocalizes with RAGE in the artery wall and promotes MCP-1 expression via the RAGE-Erk1/2 MAP-kinase pathway.

Authors:  Gunther Marsche; Michaela Semlitsch; Astrid Hammer; Sasa Frank; Bernd Weigle; Nina Demling; Kurt Schmidt; Werner Windischhofer; Georg Waeg; Wolfgang Sattler; Ernst Malle
Journal:  FASEB J       Date:  2007-01-11       Impact factor: 5.191

9.  Local gene silencing of monocyte chemoattractant protein-1 prevents vulnerable plaque disruption in apolipoprotein E-knockout mice.

Authors:  Xiao Ling Liu; Peng Fei Zhang; Shi Fang Ding; Yan Wang; Mei Zhang; Yu Xia Zhao; Mei Ni; Yun Zhang
Journal:  PLoS One       Date:  2012-03-12       Impact factor: 3.240

10.  Pre-treatment with simvastatin prevents the induction of diet-induced atherosclerosis in a rabbit model.

Authors:  Nikolaos Oikonomidis; Nikolaos Kavantzas; Laskarina-Maria Korou; Panagiotis Konstantopoulos; Vasilios Pergialiotis; Evangelos Misiakos; Ioannis Rizos; Christos Verikokos; Despina N Perrea
Journal:  Biomed Rep       Date:  2016-10-17
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.